Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement
Press Release – New York – July 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that acted as US counsel to Australian-based stem cell and regenerative medicine provider Cynata Therapeutics Limited (ASX: CYP) in connection with a A$5 million private placement. The offering consisted of 6,670,000 shares of Cynata’s common stock and warrants priced at A$0.75 per share.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and David Manno. H.C. Wainwright & Co. acted as the sole placement agent on the offering.
- Sichenzia Ross Ference LLP Represents EzFill in $28.75 Million Initial Public Offering and NASDAQ Listing - September 20, 2021
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $81 Million Underwritten Public Offering for Farmmi, Inc. - September 15, 2021
- Sichenzia Ross Ference LLP Secures Deferred Prosecution Agreement for Client Under Federal Indictment in the Southern District of New York - September 13, 2021